Nyxoah S.A. (NYXH)
NASDAQ: NYXH · IEX Real-Time Price · USD
9.76
-0.06 (-0.61%)
At close: May 3, 2024, 4:00 PM
10.11
+0.35 (3.60%)
After-hours: May 3, 2024, 4:42 PM EDT

Nyxoah Revenue

In the year 2023, Nyxoah had annual revenue of $4.83M with 47.25% growth. Revenue in the quarter ending December 31, 2023 was $2.03M with 45.76% year-over-year growth.

Revenue (ttm)
$4.83M
Revenue Growth
+47.25%
P/S Ratio
57.90
Revenue / Employee
$33,090
Employees
146
Market Cap
279.74M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.83M1.55M47.25%
Dec 31, 20223.28M2.31M238.87%
Dec 31, 2021968.18K884.04K1,050.60%
Dec 31, 202084.15K--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 192.64M
Xeris Biopharma Holdings 163.91M
ChromaDex 83.57M
Codexis 74.23M
Sanara MedTech 64.99M
Poseida Therapeutics 64.70M
Opthea 385.28K
Revenue Rankings